Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Outdoor Guide
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
Readersâ Choice
Auction
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Century Therapeutics, Inc.
Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
May 11, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit
April 17, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Announces Leadership Changes
April 12, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates
March 16, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the AACR Annual Meeting 2023
March 15, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at Upcoming Investor Conferences
February 21, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas
February 08, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at Upcoming Investor Conferences
February 01, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026
January 05, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Announces Presentation of Preclinical Data at the SITC 37th Annual Meeting and Provides Pipeline Updates
November 11, 2022
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 10, 2022
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Host Virtual Research and Development Day on November 11, 2022
November 02, 2022
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the SITC 37th Annual Meeting
October 05, 2022
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Announces Appointment of Daphne Quimi and Timothy Walbert to its Board of Directors
October 03, 2022
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.